RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: transient cerebral ischemia
Accession: DOID:224
browse the term
Definition: A brain ischemia that is characterized by ischemia of brief duration and without resultant tissue death. (DO)
Synonyms: exact_synonym: Brain Stem Ischemia, Transient; Brain Stem Transient Ischemic Attack; Brain TIA; Brainstem Transient Ischemic Attack; Carotid Circulation Transient Ischemic Attack; Posterior Circulation Transient Ischemic Attack; TIA; TIA (Transient Ischemic Attack); TIA - transient ischaemic attack; Transient Brainstem Ischemia; Transient Cerebral Ischemias; Transient cerebral ischaemia; anterior circulation transient ischemic attack; crescendo transient ischemic attacks; transient brainstem ischemias; transient ischemic attack; transient ischemic attacks; vertebrobasilar circulation transient ischemic attack
related_synonym: Brain Ischemia-Reperfusion Injury; Brain Reperfusion Injury
primary_id: MESH:D002546
xref: EFO:0003764 ; ICD10CM:G45.9 ; NCI:C50781
For additional species annotation, visit the
Alliance of Genome Resources .
G
Acvrl1
activin A receptor, type II-like 1
ISO
RGD
PMID:15781474
RGD:1579751
NCBI chr15:101,026,403...101,043,217
Ensembl chr15:101,026,403...101,043,217
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
mRNA, protein:increased expression:brain
RGD
PMID:16630594
RGD:9681747
NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001
G
Adamts4
ADAM metallopeptidase with thrombospondin type 1 motif 4
ISO
RGD
PMID:16630594
RGD:9681747
NCBI chr 1:171,077,698...171,089,836
Ensembl chr 1:171,077,990...171,088,206
G
Adarb1
adenosine deaminase, RNA-specific, B1
ISO
RGD
PMID:16504947
RGD:10755337
NCBI chr10:77,126,561...77,254,125
Ensembl chr10:77,126,560...77,254,104
G
Adora1
adenosine A1 receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23437309
NCBI chr 1:134,126,953...134,163,195
Ensembl chr 1:134,126,963...134,163,169
G
Ager
advanced glycosylation end product-specific receptor
ISO IEP
protein:altered expression:cerebral cortex, striatum (rat) protein:increased expression:brain, plasma
RGD
PMID:22528836 PMID:23288172
RGD:7245542 , RGD:8696004
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Agt
angiotensinogen
ISO
RGD
PMID:21934531
RGD:8549480
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Ahr
aryl-hydrocarbon receptor
treatment
ISO
RGD
PMID:32913241
RGD:401793747
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Aifm1
apoptosis-inducing factor, mitochondrion-associated 1
ISO IEP
mRNA:decreased expression, altered localization:CA1 pyramidal layer, nucleus: protein:increased expression:nucleus:
RGD
PMID:14526224 PMID:15087715
RGD:10047409 , RGD:10053562
NCBI chr X:47,563,821...47,602,440
Ensembl chr X:47,563,821...47,602,440
G
Ang
angiogenin, ribonuclease, RNase A family, 5
treatment
ISO
RGD
PMID:30258350
RGD:155663419
NCBI chr14:51,328,607...51,339,462
Ensembl chr14:51,328,607...51,339,466
G
Ank1
ankyrin 1, erythroid
ISO
RGD
PMID:9202331
RGD:1599109
NCBI chr 8:23,464,852...23,640,517
Ensembl chr 8:23,464,860...23,640,513
G
Ank2
ankyrin 2, brain
ISO
RGD
PMID:9202331
RGD:1599109
NCBI chr 3:126,715,256...127,293,996
Ensembl chr 3:126,715,261...127,292,999
G
Apoe
apolipoprotein E
ISO
RGD
PMID:19623195
RGD:6903926
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
Aqp4
aquaporin 4
treatment
ISO
RGD
PMID:24773551
RGD:13207320
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
G
Atf2
activating transcription factor 2
ISO
RGD
PMID:10077326 PMID:9813301
RGD:10047405 , RGD:10047413
NCBI chr 2:73,646,853...73,723,094
Ensembl chr 2:73,646,853...73,722,983
G
Atp5f1b
ATP synthase F1 subunit beta
ISO
protein:increased expression:cerebrum (rat)
RGD
PMID:21950801
RGD:13792582
NCBI chr10:127,919,176...127,926,257
Ensembl chr10:127,919,142...127,926,260
G
Axin2
axin 2
treatment
ISO
RGD
PMID:31650542
RGD:151356749
NCBI chr11:108,808,687...108,841,609
Ensembl chr11:108,811,175...108,841,609
G
Bace1
beta-site APP cleaving enzyme 1
ISO
protein:increased activity,increased expression:brain cortex
RGD
PMID:15120577
RGD:13782170
NCBI chr 9:45,749,878...45,775,694
Ensembl chr 9:45,749,878...45,775,697
G
Bad
BCL2-associated agonist of cell death
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12629175
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
Bax
BCL2-associated X protein
treatment
ISO
RGD
PMID:21167243
RGD:10054102
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bbc3
BCL2 binding component 3
ISO
protein:increased expression:hippocampus CA1, pyramidal cell
RGD
PMID:12913114
RGD:634629
NCBI chr 7:16,042,307...16,052,130
Ensembl chr 7:16,042,318...16,052,130
G
Bcl2
B cell leukemia/lymphoma 2
treatment
ISO
protein:decreased expression:brain
RGD
PMID:18083315 PMID:16732092 PMID:22509406
RGD:2290557 , RGD:11522725 , RGD:11561910
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bcl2l2
BCL2-like 2
treatment
ISO
protein:increased expression:cortex and caudate putamen
RGD
PMID:10724126 PMID:12571640
RGD:14394498 , RGD:14394500
NCBI chr14:55,120,900...55,125,691
Ensembl chr14:55,120,834...55,125,691 Ensembl chr14:55,120,834...55,125,691
G
Becn1
beclin 1, autophagy related
treatment
ISO
RGD
PMID:22509406
RGD:11561910
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
G
Bex3
brain expressed X-linked 3
ISO
RGD
PMID:11124986
RGD:9743974
NCBI chr X:135,171,002...135,172,727
Ensembl chr X:135,171,002...135,172,727
G
Bnip3
BCL2/adenovirus E1B interacting protein 3
ISO
RGD
PMID:14972662
RGD:2314028
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
G
C3
complement component 3
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23199288 PMID:22004711
RGD:7411628
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Cab39
calcium binding protein 39
ISO
protein:increased expression:brain
RGD
PMID:27798271
RGD:14398833
NCBI chr 1:85,721,148...85,779,298
Ensembl chr 1:85,721,162...85,779,297
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
ISO IEP
protein:increased expression:hippocampus
RGD
PMID:12951199 PMID:12199152
RGD:7241547 , RGD:13681927
NCBI chr18:61,058,704...61,121,224
Ensembl chr18:61,058,690...61,121,224
G
Casp3
caspase 3
ISO
RGD
PMID:21712070
RGD:10053706
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp7
caspase 7
treatment
ISO
RGD
PMID:25872160
RGD:13782285
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
G
Casp8
caspase 8
treatment
ISO
protein:increased expression:cerebral cortex:
RGD
PMID:30148677 PMID:18096138
RGD:13782286 , RGD:4142863
NCBI chr 1:58,834,398...58,886,662
Ensembl chr 1:58,834,533...58,886,662
G
Casp9
caspase 9
ISO
associated with Diabetes Mellitus, Experimental;protein:increased expression:neocortex CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11333366 PMID:15246841 PMID:21712070
RGD:2311321 , RGD:10053706
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cav1
caveolin 1, caveolae protein
treatment
ISO IMP
RGD
PMID:22007835 PMID:22007835
RGD:8661794 , RGD:8661794
NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451
G
Cbl
Casitas B-lineage lymphoma
treatment
ISO
RGD
PMID:18773943
RGD:4108486
NCBI chr 9:44,054,273...44,145,556
Ensembl chr 9:44,054,273...44,145,346
G
Cbs
cystathionine beta-synthase
treatment
IMP
XCO:0000348 XCO:0000807
RGD
PMID:22212488 PMID:22212488
RGD:41410880 , RGD:41410880
NCBI chr17:31,831,602...31,856,170
Ensembl chr17:31,827,868...31,856,212
G
Ccl2
C-C motif chemokine ligand 2
treatment
ISO
mRNA:increased expression:brain (rat)
RGD
PMID:21487414 PMID:7860708
RGD:8549519 , RGD:8549729
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl20
C-C motif chemokine ligand 20
treatment
ISO
RGD
PMID:19428685
RGD:7488896
NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
G
Ccnh
cyclin H
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:10501206
RGD:69371
NCBI chr13:85,337,504...85,361,850
Ensembl chr13:85,337,527...85,371,588
G
Ccr6
C-C motif chemokine receptor 6
ISO
mRNA:increased expression:brain
RGD
PMID:19428685
RGD:7488896
NCBI chr17:8,454,875...8,477,353
Ensembl chr17:8,454,875...8,475,973
G
Cd40
CD40 antigen
severity
IMP
RGD
PMID:15795333
RGD:11352234
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cd40lg
CD40 ligand
severity
IMP
RGD
PMID:15795333
RGD:11352234
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
G
Cdk5
cyclin dependent kinase 5
treatment
ISO
RGD
PMID:28254431
RGD:13506925
NCBI chr 5:24,612,595...24,628,737
Ensembl chr 5:24,623,239...24,628,528
G
Cdkn2a
cyclin dependent kinase inhibitor 2A
IEP
protein:decreased expression:striatum, neuron
RGD
PMID:11438580
RGD:8552691
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
G
Cebpa
CCAAT/enhancer binding protein alpha
ISO
mRNA, protein:increased expression:hippocampal pyramidal cell layer (rat)
RGD
PMID:9795105
RGD:10401192
NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
G
Chka
choline kinase alpha
ISO
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:16300643
RGD:10401831
NCBI chr19:3,901,585...3,944,368
Ensembl chr19:3,901,773...3,944,369
G
Coq7
demethyl-Q 7
severity
IMP
RGD
PMID:20170652
RGD:10402096
NCBI chr 7:118,108,881...118,132,529
Ensembl chr 7:118,108,882...118,132,579
G
Creb1
cAMP responsive element binding protein 1
ISO
RGD
PMID:10077326
RGD:10047405
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
G
Crem
cAMP responsive element modulator
ISO
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:12437578
RGD:632385
NCBI chr18:3,263,181...3,337,688
Ensembl chr18:3,266,048...3,337,748
G
Csf3
colony stimulating factor 3 (granulocyte)
treatment
ISO
RGD
PMID:12624302
RGD:10450512
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
protein:decreased expression:hippocampus
RGD
PMID:24447880
RGD:9491776
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
G
Cx3cr1
C-X3-C motif chemokine receptor 1
ISO
mRNA,protein:decreased expression:hippocampus
RGD
PMID:24447880
RGD:9491776
NCBI chr 9:119,877,749...119,897,362
Ensembl chr 9:119,730,682...119,898,945
G
Cxcl12
C-X-C motif chemokine ligand 12
ISO
protein:increased expression:hippocampus:
RGD
PMID:24924806
RGD:11352662
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
G
Cycs
cytochrome c, somatic
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11333366
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
G
Daxx
Fas death domain-associated protein
treatment
ISO
mRNA,protein:increased expression:cerebral cortex:
RGD
PMID:17967739 PMID:18096138
RGD:9587802 , RGD:4142863
NCBI chr17:34,128,379...34,134,564
Ensembl chr17:34,128,388...34,134,564
G
Dbn1
drebrin 1
ISO
RGD
PMID:8583659
RGD:10398814
NCBI chr13:55,621,241...55,635,959
Ensembl chr13:55,621,242...55,635,924
G
Dffb
DNA fragmentation factor, beta subunit
ISO
mRNA, protein:increased expression:hippocampus CA1
RGD
PMID:11425895
RGD:628524
NCBI chr 4:154,048,904...154,059,578
Ensembl chr 4:154,048,906...154,059,583
G
Dll4
delta like canonical Notch ligand 4
ameliorates disease_progression treatment
IMP ISO
RGD
PMID:31927543 PMID:30653356 PMID:30258350
RGD:155663354 , RGD:155663383 , RGD:155663419
NCBI chr 2:119,156,265...119,166,147
Ensembl chr 2:119,156,265...119,166,443
G
Dusp1
dual specificity phosphatase 1
ISO
protein:increased expression:brain
RGD
PMID:22197701
RGD:7771582
NCBI chr17:26,724,565...26,727,446
Ensembl chr17:26,724,564...26,781,102
G
Dusp16
dual specificity phosphatase 16
ISO
protein:increased expression, altered localization:hippocampus, cytosol, nucleus
RGD
PMID:23280045
RGD:7775014
NCBI chr 6:134,692,431...134,769,687
Ensembl chr 6:134,692,431...134,769,588
G
Eed
embryonic ectoderm development
ISO
RGD
PMID:24007266
RGD:9588303
NCBI chr 7:89,603,862...89,630,184
Ensembl chr 7:89,603,862...89,630,191
G
Eif2s1
eukaryotic translation initiation factor 2, subunit 1 alpha
IDA ISO
associated with Heart Arrest
RGD
PMID:11520898 PMID:10541873
RGD:10395353 , RGD:11041881
NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784
G
Elane
elastase, neutrophil expressed
treatment
ISO
RGD
PMID:19168036
RGD:10450558
NCBI chr10:79,722,146...79,724,050
Ensembl chr10:79,722,081...79,724,049
G
Elk1
ELK1, member of ETS oncogene family
treatment
ISO
RGD
PMID:17091294
RGD:7488902
NCBI chr X:20,799,634...20,816,847
Ensembl chr X:20,799,634...20,816,847
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
ISO
mRNA:increased expression:brain:
RGD
PMID:9634555
RGD:9685492
NCBI chr19:40,600,810...40,730,046
Ensembl chr19:40,600,810...40,730,046
G
Ep300
E1A binding protein p300
ISO
mRNA:increased expression:cerebrum, ipsilateral side (rat)
RGD
PMID:22196858
RGD:7349341
NCBI chr15:81,470,329...81,536,278
Ensembl chr15:81,469,552...81,536,278
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:22282883 PMID:24702327
RGD:10401060 , RGD:11041699
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
Ercc1
excision repair cross-complementing rodent repair deficiency, complementation group 1
treatment
ISO
human gene in a rat model
RGD
PMID:19440222
RGD:2313668
NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449
G
Ercc6
excision repair cross-complementing rodent repair deficiency, complementation group 6
ISO
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:10437118
RGD:10401104
NCBI chr14:32,235,248...32,302,947
Ensembl chr14:32,235,478...32,302,947
G
Esr1
estrogen receptor 1 (alpha)
treatment
ISO
RGD
PMID:24548484 PMID:25098259
RGD:10045843 , RGD:10045845
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Esr2
estrogen receptor 2 (beta)
ISO
RGD
PMID:23593292
RGD:7364962
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
F11r
F11 receptor
treatment
ISO
RGD
PMID:22868201
RGD:7488943
NCBI chr 1:171,265,129...171,292,161
Ensembl chr 1:171,265,103...171,292,171
G
F12
coagulation factor XII (Hageman factor)
treatment
IMP ISO
RGD
PMID:16533887 PMID:16533887
RGD:11041786 , RGD:11041786
NCBI chr13:55,565,771...55,574,617
Ensembl chr13:55,565,771...55,574,606
G
Fadd
Fas associated via death domain
ISO
mRNA,protein:increased expression:cerebral cortex:
RGD
PMID:18096138
RGD:4142863
NCBI chr 7:144,132,060...144,136,178
Ensembl chr 7:144,131,055...144,136,200
G
Fas
Fas cell surface death receptor
treatment
ISO IMP
protein:increased expression:brain (rat)
RGD
PMID:18410517 PMID:10972965 PMID:18981705 PMID:30301943
RGD:2311437 , RGD:8662928 , RGD:8686422 , RGD:153297779
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fgfr1
fibroblast growth factor receptor 1
ISO
mRNA:increased expression:cerebral cortex:
RGD
PMID:8858623
RGD:10402044
NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734
G
Fgfr2
fibroblast growth factor receptor 2
treatment
ISO
associated with Experimental Diabetes Mellitus
RGD
PMID:22432030
RGD:155882598
NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079
G
Flt1
FMS-like tyrosine kinase 1
treatment
IDA
RGD
PMID:17077813
RGD:10402150
NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821
G
Fmr1
fragile X messenger ribonucleoprotein 1
ISO
mRNA, protein:increased expression:striatum (rat)
RGD
PMID:22817682
RGD:11566024
NCBI chr X:67,722,144...67,761,569
Ensembl chr X:67,722,147...67,761,569
G
Fto
FTO alpha-ketoglutarate dependent dioxygenase
ISO IEP
protein:decreased expression:cerebral cortex mRNA:decreased expression:heart mRNA:decreased expression:cerebral cortex
RGD
PMID:32426101 PMID:34413770 PMID:36479246
RGD:329901764 , RGD:329901768 , RGD:329951019
NCBI chr 8:92,039,995...92,395,061
Ensembl chr 8:92,040,153...92,395,067
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
ISO
RGD
PMID:22580330
RGD:10449127
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Gad1
glutamate decarboxylase 1
disease_progression
ISO
RGD
PMID:20659561
RGD:401900597
NCBI chr 2:70,391,644...70,432,358
Ensembl chr 2:70,383,416...70,432,358
G
Gad2
glutamic acid decarboxylase 2
disease_progression
ISO
RGD
PMID:20659561
RGD:401900597
NCBI chr 2:22,512,262...22,583,889
Ensembl chr 2:22,512,217...22,583,886
G
Gamt
guanidinoacetate methyltransferase
ameliorates
IMP
DNA:deletion
RGD
PMID:24004504
RGD:329955375
NCBI chr10:80,093,985...80,096,846
Ensembl chr10:80,093,985...80,096,846
G
Gatm
glycine amidinotransferase (L-arginine:glycine amidinotransferase)
exacerbates
IMP
DNA:deletion
RGD
PMID:24004504
RGD:329955375
NCBI chr 2:122,424,954...122,441,758
Ensembl chr 2:122,424,948...122,441,784
G
Gch1
GTP cyclohydrolase 1
treatment
ISO
RGD
PMID:9920651
RGD:329961573
NCBI chr14:47,391,352...47,426,870
Ensembl chr14:47,391,352...47,426,870
G
Ghsr
growth hormone secretagogue receptor
ISO
mRNA,protein:decreased expression:brain:
RGD
PMID:17560544
RGD:12907500
NCBI chr 3:27,425,500...27,433,384
Ensembl chr 3:27,425,500...27,432,159
G
Gja1
gap junction protein, alpha 1
treatment
IDA ISO
protein:increased expression:brain
RGD
PMID:22812228 PMID:23328809
RGD:7207263 , RGD:8662426
NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609
G
Gjb6
gap junction protein, beta 6
ISO
protein:increased expression:hippocampus:
RGD
PMID:21718970
RGD:6480433
NCBI chr14:57,360,758...57,371,068
Ensembl chr14:57,360,760...57,371,068
G
Glrx
glutaredoxin
ISO
mRNA,protein:decreased expression:brain:
RGD
PMID:10329397
RGD:9686043
NCBI chr13:75,988,004...75,998,270
Ensembl chr13:75,987,987...75,998,273
G
Glul
glutamate-ammonia ligase
treatment
ISO
protein:increased expression:hippocampus associated with carotid artery occlusion
RGD
PMID:27664163 PMID:21371894 PMID:21272618 PMID:25365917
RGD:401794415 , RGD:401794419 , RGD:401794590 , RGD:401794591
NCBI chr 1:153,775,692...153,785,469
Ensembl chr 1:153,775,690...153,785,469
G
Got1
glutamic-oxaloacetic transaminase 1, soluble
treatment
ISO IDA
human protein in a rat model
RGD
PMID:24407245 PMID:20145654 PMID:21361730
RGD:13504852 , RGD:13504854 , RGD:13504855
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
G
Gp6
glycoprotein 6 platelet
ameliorates
IMP
RGD
PMID:34237320
RGD:401794450
NCBI chr 7:4,365,852...4,400,849
Ensembl chr 7:4,366,964...4,400,743
G
Gpx3
glutathione peroxidase 3
treatment
ISO
RGD
PMID:30098076
RGD:401827833
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
G
Gsr
glutathione reductase
treatment
ISO
RGD
PMID:15525350
RGD:10401855
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
H2ax
H2A.X variant histone
treatment
ISO
RGD
PMID:20830300
RGD:8693742
NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
G
Havcr2
hepatitis A virus cellular receptor 2
treatment
ISO
RGD
PMID:24771108
RGD:9686115
NCBI chr11:46,345,758...46,372,082
Ensembl chr11:46,345,762...46,372,082
G
Hif1a
hypoxia inducible factor 1, alpha subunit
treatment
ISO
protein:increased expression:cerebral cortex, caudoputamen (rat)
RGD
PMID:20417628 PMID:30258350
RGD:9068877 , RGD:155663419
NCBI chr12:73,948,098...73,994,328
Ensembl chr12:73,948,149...73,994,304
G
Hmgb1
high mobility group box 1
IEP
protein:increased expression:brain, plasma
RGD
PMID:23288172
RGD:8696004
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
ISO
protein:altered expression:cerebral cortex, hippocampus (rat)
RGD
PMID:20421594
RGD:10041006
NCBI chr 6:51,437,414...51,448,054
Ensembl chr 6:51,437,912...51,446,874
G
Hnrnpab
heterogeneous nuclear ribonucleoprotein A/B
treatment
ISO
RGD
PMID:22366221
RGD:9999181
NCBI chr11:51,490,927...51,497,708
Ensembl chr11:51,490,927...51,497,674
G
Hrh2
histamine receptor H2
ISO
protein:decreased expression:caudate putamen (rat)
RGD
PMID:16181737
RGD:9685533
NCBI chr13:54,345,990...54,390,201
Ensembl chr13:54,346,148...54,390,199
G
Hsf1
heat shock factor 1
treatment
ISO
protein:increased expression:brain, nucleus (rat) associated with Heart Arrest
RGD
PMID:26070787 PMID:23528677
RGD:10402389 , RGD:10402772
NCBI chr15:76,361,562...76,385,355
Ensembl chr15:76,361,622...76,386,113
G
Hspa5
heat shock protein 5
treatment
ISO
RGD
PMID:25632565
RGD:11354959
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
G
Hspa8
heat shock protein 8
ISO
protein:increased expression:brain, postsynaptic density (rat)
RGD
PMID:9425004
RGD:10059344
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
G
Hspb1
heat shock protein 1
ISO
protein:increased expression:brain,astrocyte:
RGD
PMID:10559386
RGD:10402577
NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
G
Htra2
HtrA serine peptidase 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15306124 PMID:19462455
RGD:10402932
NCBI chr 6:83,028,247...83,031,552
Ensembl chr 6:83,028,247...83,032,254
G
Htt
huntingtin
ISO
protein:increased degradation:brain
RGD
PMID:12957494
RGD:1304431
NCBI chr 5:34,919,084...35,069,878
Ensembl chr 5:34,919,084...35,069,878
G
Icam1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:22379785
RGD:8547729
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ifnb1
interferon beta 1, fibroblast
ameliorates
ISO
RGD
PMID:12973019
RGD:401851924
NCBI chr 4:88,440,253...88,441,083
Ensembl chr 4:88,440,262...88,441,011
G
Igf1
insulin-like growth factor 1
severity
ISO
protein:decreased expression:serum (rat)
RGD
PMID:25098324
RGD:12904924
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Ikbkb
inhibitor of kappaB kinase beta
treatment
ISO
RGD
PMID:24261295
RGD:7495766
NCBI chr 8:23,149,221...23,196,605
Ensembl chr 8:23,149,228...23,196,605
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:24053818
RGD:7364868
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il1b
interleukin 1 beta
ISO IDA
RGD
PMID:23147509 PMID:22284622
RGD:7175551 , RGD:7175554
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
ISO
human protein in a rat model
RGD
PMID:15837124 PMID:20412072
RGD:1626674 , RGD:8551852
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Ilk
integrin linked kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15472100
NCBI chr 7:105,385,797...105,392,132
Ensembl chr 7:105,385,799...105,392,132
G
Itgam
integrin alpha M
treatment
IEP ISO
mRNA:increased expression:cerebral cortex (mouse) mRNA:increased expression:brain (rat)
RGD
PMID:30123113 PMID:8160235 PMID:8581506 PMID:8964796 PMID:19563786 PMID:32407868 PMID:22082476 PMID:23844255 More...
RGD:329853754 , RGD:329901916 , RGD:329901917 , RGD:329901921 , RGD:329901933 , RGD:329901940 , RGD:329902058 , RGD:329902067
NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663
G
Itgb3
integrin beta 3
ISO
RGD
PMID:18638458
RGD:6907424
NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
G
Itpr1
inositol 1,4,5-trisphosphate receptor 1
ISO
mRNA:decreased expression:cerebral cortex (rat)
RGD
PMID:7500836
RGD:6482813
NCBI chr 6:108,190,044...108,528,077
Ensembl chr 6:108,190,057...108,528,070
G
Jak1
Janus kinase 1
ISO
RGD
PMID:10756075
RGD:19165138
NCBI chr 4:101,009,171...101,122,493
Ensembl chr 4:101,009,564...101,122,479
G
Jak2
Janus kinase 2
ISO
RGD
PMID:23764464
RGD:8694326
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Kcnj10
potassium inwardly-rectifying channel, subfamily J, member 10
ISO
protein:decreased expression:CA1 field of hippocampus, astrocyte, astrocyte projection
RGD
PMID:20833221
RGD:8662899
NCBI chr 1:172,168,777...172,201,652
Ensembl chr 1:172,168,777...172,201,652
G
Kcnk2
potassium channel, subfamily K, member 2
severity treatment
IMP ISO
protein:increased expression:cerebral cortex (rat)
RGD
PMID:15175651 PMID:25062759 PMID:24154701
RGD:9831121 , RGD:9831122 , RGD:9831178
NCBI chr 1:188,940,127...189,134,951
Ensembl chr 1:188,940,127...189,134,470
G
Kdm1a
lysine (K)-specific demethylase 1A
ISO
protein:increased expression:cerebral cortex, hippocampus, dentate gyrus (rat)
RGD
PMID:20542065
RGD:9588301
NCBI chr 4:136,277,844...136,330,127
Ensembl chr 4:136,277,851...136,330,034
G
Keap1
kelch-like ECH-associated protein 1
IEP
protein:decreased expression:brain (mouse)
RGD
PMID:21075092
RGD:6893270
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
G
Klf5
Kruppel-like transcription factor 5
ameliorates
ISO
RGD
PMID:32272873
RGD:45073134
NCBI chr14:99,536,127...99,550,848
Ensembl chr14:99,536,127...99,552,472
G
Kmt2a
lysine (K)-specific methyltransferase 2A
treatment
ISO
RGD
PMID:34694864
RGD:155888565
NCBI chr 9:44,714,652...44,793,492
Ensembl chr 9:44,714,652...44,792,594
G
Lcn2
lipocalin 2
ISO
protein:increased expression:brain
RGD
PMID:29122651 PMID:24916903
RGD:126781757 , RGD:126790489
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Lmna
lamin A
ISO
RGD
PMID:17683050
RGD:2293745
NCBI chr 3:88,388,455...88,413,842
Ensembl chr 3:88,387,454...88,417,263
G
Lpar1
lysophosphatidic acid receptor 1
treatment
ISO
RGD
PMID:17173873
RGD:9850154
NCBI chr 4:58,435,252...58,554,601
Ensembl chr 4:58,435,255...58,553,898
G
Ltbp1
latent transforming growth factor beta binding protein 1
treatment
ISO
RGD
PMID:11720783
RGD:10412057
NCBI chr17:75,312,475...75,699,507
Ensembl chr17:75,312,563...75,699,507
G
Madd
MAP-kinase activating death domain
ISO
RGD
PMID:12625816
RGD:9588641
NCBI chr 2:90,967,705...91,013,404
Ensembl chr 2:90,967,705...91,014,182
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
ISO
RGD
PMID:22509406
RGD:11561910
NCBI chr 2:155,118,284...155,119,993
Ensembl chr 2:155,118,217...155,119,993
G
Map2k4
mitogen-activated protein kinase kinase 4
ISO
protein:increased threonine phosphorylation:heart, nucleus
RGD
PMID:9195981
RGD:7495830
NCBI chr11:65,579,070...65,679,185
Ensembl chr11:65,579,069...65,679,123
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
ISO
protein:increased nitrosylation, activity:hippocampus:
RGD
PMID:23137546
RGD:10412334
NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499
G
Map3k7
mitogen-activated protein kinase kinase kinase 7
ameliorates
IMP
RGD
PMID:32078472 PMID:32382778 PMID:34628598 PMID:32349637
RGD:155791642 , RGD:155804272 , RGD:155804283 , RGD:155804284
NCBI chr 4:31,963,659...32,023,470
Ensembl chr 4:31,964,097...32,023,467
G
Map4k1
mitogen-activated protein kinase kinase kinase kinase 1
treatment
ISO
RGD
PMID:18498770 PMID:18382279
RGD:7495845 , RGD:7495847
NCBI chr 7:28,681,475...28,702,704
Ensembl chr 7:28,681,475...28,702,704
G
Mbd1
methyl-CpG binding domain protein 1
ISO
mRNA:increased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr18:74,400,676...74,415,808
Ensembl chr18:74,400,676...74,415,803
G
Mbd2
methyl-CpG binding domain protein 2
ISO
mRNA:increased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr18:70,701,298...70,761,769
Ensembl chr18:70,701,260...70,759,202
G
Mbd3
methyl-CpG binding domain protein 3
ISO
mRNA:decreased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr10:80,228,373...80,235,365
Ensembl chr10:80,228,373...80,235,384
G
Mbp
myelin basic protein
ISO
mRNA:increased expression:oligodendrocyte:
RGD
PMID:11460777
RGD:7349336
NCBI chr18:82,492,883...82,603,762
Ensembl chr18:82,493,271...82,603,762
G
Mcfd2
multiple coagulation factor deficiency 2
ISO
mRNA:increased expression:hippocampus
RGD
PMID:17610559
RGD:11062141
NCBI chr17:87,561,871...87,573,382
Ensembl chr17:87,561,871...87,573,363
G
Mdm2
transformed mouse 3T3 cell double minute 2
treatment
ISO
RGD
PMID:24334056
RGD:10412310
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
G
Mecp2
methyl CpG binding protein 2
ISO
mRNA:increased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr X:73,070,198...73,129,296
Ensembl chr X:73,070,198...73,178,969
G
Mff
mitochondrial fission factor
treatment
ISO
RGD
PMID:26116440
RGD:12879457
NCBI chr 1:82,702,599...82,730,111
Ensembl chr 1:82,702,611...82,730,115
G
Mfn2
mitofusin 2
ISO
protein:decreased expression:brain (rat)
RGD
PMID:25147362
RGD:13204807
NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
G
Mir126a
microRNA 126a
exacerbates
IMP
RGD
PMID:28101763
RGD:401850574
NCBI chr 2:26,481,369...26,481,441
Ensembl chr 2:26,481,369...26,481,441
G
Mir155
microRNA 155
treatment
ISO
RGD
PMID:33081480
RGD:151347423
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mir195a
microRNA 195a
severity
ISO
RGD
PMID:32272873
RGD:45073134
NCBI chr11:70,125,868...70,125,961
Ensembl chr11:70,125,868...70,125,961
G
Mir223
microRNA 223
ISO
RGD
PMID:31237865
RGD:25824937
NCBI chr X:95,286,423...95,286,532
Ensembl chr X:95,286,423...95,286,532
G
Mmp2
matrix metallopeptidase 2
treatment
ISO
protein:increased activity, increased expression:brain
RGD
PMID:11592852 PMID:24828425
RGD:8547930 , RGD:8657086
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp9
matrix metallopeptidase 9
treatment
IMP ISO
protein:increased activity, increased expression:brain
RGD
PMID:16197500 PMID:11592852 PMID:23046750 PMID:24773551
RGD:8547921 , RGD:8547930 , RGD:13207323 , RGD:13207320
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mt1
metallothionein 1
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:10884303
RGD:10412650
NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955
G
Mt2
metallothionein 2
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:10884303
RGD:10412650
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
G
Mt3
metallothionein 3
ISO
mRNA, protein:increased expression:brain
RGD
PMID:10069533
RGD:9685804
NCBI chr 8:94,879,235...94,880,776
Ensembl chr 8:94,879,235...94,880,774
G
Mtor
mechanistic target of rapamycin kinase
treatment
ISO
RGD
PMID:30712471
RGD:155791663
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Myb
myeloblastosis oncogene
ISO
mRNA:increased expression:brain:
RGD
PMID:24828495
RGD:11532683
NCBI chr10:21,000,829...21,036,883
Ensembl chr10:21,000,834...21,036,883
G
Nampt
nicotinamide phosphoribosyltransferase
treatment
ISO
RGD
PMID:28528966 PMID:25603815
RGD:13781879 , RGD:13781895
NCBI chr12:32,870,334...32,903,368
Ensembl chr12:32,869,544...32,903,348
G
Ndrg2
N-myc downstream regulated gene 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23451161
NCBI chr14:52,142,728...52,151,461
Ensembl chr14:52,142,728...52,151,615
G
Ndrg4
N-myc downstream regulated gene 4
IMP
RGD
PMID:21636852
RGD:7247728
NCBI chr 8:96,403,602...96,441,584
Ensembl chr 8:96,403,608...96,441,747
G
Nefh
neurofilament, heavy polypeptide
ISO
protein:decreased expression:hippocampus
RGD
PMID:8726968
RGD:9743938
NCBI chr11:4,888,754...4,898,064
Ensembl chr11:4,888,754...4,898,064
G
Nefl
neurofilament, light polypeptide
ISO
protein:decreased expression:hippocampus
RGD
PMID:8726968
RGD:9743938
NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544
G
Nefm
neurofilament, medium polypeptide
ISO
protein:decreased expression:hippocampus
RGD
PMID:8726968
RGD:9743938
NCBI chr14:68,356,994...68,362,453
Ensembl chr14:68,320,039...68,362,295
G
Nf1
neurofibromin 1
ISO
mRNA,protein:increased expression:astrocyte:
RGD
PMID:8820972
RGD:12789703
NCBI chr11:79,223,541...79,472,435
Ensembl chr11:79,230,519...79,472,438
G
Nfkb1
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105
ISO
protein:increased expression:hippocampal pyramidal neuron, nucleus (rat)
RGD
PMID:9158652
RGD:10045943
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
G
Ngb
neuroglobin
treatment
ISO IDA
associated with Hypertension;mRNA, protein:decreased expression:brain
RGD
PMID:16647691 PMID:12621155 PMID:12621155 PMID:23342777
RGD:9743952 , RGD:9743964 , RGD:9743964 , RGD:9743965
NCBI chr12:87,144,305...87,149,313
Ensembl chr12:87,144,305...87,149,313
G
Ngfr
nerve growth factor receptor (TNFR superfamily, member 16)
ISO
RGD
PMID:11124986
RGD:9743974
NCBI chr11:95,459,644...95,478,524
Ensembl chr11:95,459,644...95,478,561
G
Nod2
nucleotide-binding oligomerization domain containing 2
IEP
mRNA, protein:increased expression:brain
RGD
PMID:20863826
RGD:5508733
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
G
Nono
non-POU-domain-containing, octamer binding protein
IEP
protein:altered localization:cerebral cortex (mouse)
RGD
PMID:29426953
RGD:155883175
NCBI chr X:100,473,080...100,492,199
Ensembl chr X:100,472,924...100,492,197
G
Nos1
nitric oxide synthase 1, neuronal
ISO
protein:increased serine phosphorylation:dentate gyrus
RGD
PMID:23806217
RGD:7257600
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
G
Nos3
nitric oxide synthase 3, endothelial cell
treatment
ISO
protein:increased expression:serum (rat)
RGD
PMID:28944915 PMID:29312485 PMID:29298658
RGD:13450951 , RGD:13503330 , RGD:13503353
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Notch1
notch 1
treatment
ISO
RGD
PMID:30258350
RGD:155663419
NCBI chr 2:26,347,914...26,393,834
Ensembl chr 2:26,347,915...26,406,675
G
Nox1
NADPH oxidase 1
ameliorates
ISO
RGD
PMID:25617620
RGD:329955357
NCBI chr X:132,987,170...133,038,455
Ensembl chr X:132,987,170...133,122,705
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
treatment
ISO
protein:increased expression:brain (rat) protein:increased expression:cerebral cortex (rat)
RGD
PMID:29017857 PMID:28552673 PMID:28169530
RGD:13439718 , RGD:13439727 , RGD:13442499
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nrxn1
neurexin I
ISO
associated with Hypertension;mRNA:decreased expression:cerebral cortex
RGD
PMID:12437578
RGD:632385
NCBI chr17:90,341,072...91,400,587
Ensembl chr17:90,341,059...91,400,499
G
Ogg1
8-oxoguanine DNA-glycosylase 1
ISO
protein:increased expression:cerebral cortex
RGD
PMID:14600440
RGD:8657406
NCBI chr 6:113,303,959...113,311,149
Ensembl chr 6:113,303,933...113,312,029
G
Opa1
OPA1, mitochondrial dynamin like GTPase
treatment
IEP ISO
protein:altered expression:brain
RGD
PMID:22345048 PMID:24633199
RGD:7800722 , RGD:13208946
NCBI chr16:29,398,099...29,481,924
Ensembl chr16:29,398,152...29,473,702
G
Optn
optineurin
ISO
protein:decreased expression:cerebral cortex (rat)
RGD
PMID:24235151
RGD:13434905
NCBI chr 2:5,023,902...5,069,210
Ensembl chr 2:5,025,453...5,068,862
G
Parl
presenilin associated, rhomboid-like
severity
IMP
RGD
PMID:23921894
RGD:12902620
NCBI chr16:20,098,570...20,121,090
Ensembl chr16:20,098,568...20,121,137
G
Parp1
poly (ADP-ribose) polymerase family, member 1
treatment
ISO
RGD
PMID:19840223 PMID:19840223
RGD:2325713 , RGD:2325713
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pawr
PRKC, apoptosis, WT1, regulator
ISO IEP
mRNA:increased expression:brain: protein:increased expression:cortex,striatum:
RGD
PMID:14705148 PMID:11323519
RGD:1302269 , RGD:9835381
NCBI chr10:108,168,050...108,250,708
Ensembl chr10:108,167,982...108,250,101
G
Pax6
paired box 6
ISO
protein:increased expression:cerebral cortex, striatum, astroglial cell (rat)
RGD
PMID:24114637
RGD:8552354
NCBI chr 2:105,499,241...105,528,755
Ensembl chr 2:105,499,245...105,527,709
G
Pcna
proliferating cell nuclear antigen
ISO
RGD
PMID:9757027
RGD:10448974
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
G
Pde4d
phosphodiesterase 4D, cAMP specific
ISO
protein:increased expression:hippocampus CA1
RGD
PMID:22860212
RGD:7327148
NCBI chr13:108,790,711...110,092,503
Ensembl chr13:108,586,482...110,089,995
G
Pdyn
prodynorphin
ISO
mRNA:decreased expression:dentate gyrus, granule cell
RGD
PMID:8914861
RGD:401851049
NCBI chr 2:129,528,469...129,541,858
Ensembl chr 2:129,528,485...129,541,764
G
Pecam1
platelet/endothelial cell adhesion molecule 1
IEP
protein:increased expression:brain (mouse)
RGD
PMID:22382321
RGD:6766379
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Plat
plasminogen activator, tissue
ISO
Protein:increased expression, increased activity:hippocampus (rat)
RGD
PMID:15882815
RGD:1580875
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Plau
plasminogen activator, urokinase
ISO
protein:increased expression:cerebral cortex (rat)
RGD
PMID:21375013 PMID:19952306
RGD:7241584 , RGD:7241795
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Plxnd1
plexin D1
ameliorates
ISO
RGD
PMID:30653356
RGD:155663383
NCBI chr 6:115,931,772...115,972,300
Ensembl chr 6:115,931,772...115,971,966
G
Pparg
peroxisome proliferator activated receptor gamma
ISO IMP
RGD
PMID:18378216 PMID:18973594 PMID:19221220
RGD:2301892 , RGD:2301866 , RGD:8553032
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
ISO
protein:increased expression:cerebral cortex (rat)
RGD
PMID:15255948
RGD:9999154
NCBI chr 7:45,172,341...45,175,692
Ensembl chr 7:45,172,340...45,175,692
G
Ppp1r9a
protein phosphatase 1, regulatory subunit 9A
treatment
ISO
RGD
PMID:21278085
RGD:10043805
NCBI chr 6:4,902,702...5,165,661
Ensembl chr 6:4,902,917...5,165,661
G
Ppp2r5e
protein phosphatase 2, regulatory subunit B', epsilon
treatment
ISO
RGD
PMID:30712471
RGD:155791663
NCBI chr12:75,496,237...75,643,064
Ensembl chr12:75,497,655...75,643,019
G
Prkn
parkin RBR E3 ubiquitin protein ligase
IEP
protein:decreased expression:cerebral cortex, striatum:
RGD
PMID:12415119
RGD:10413862
NCBI chr17:11,059,227...12,282,257
Ensembl chr17:11,059,271...12,282,248
G
Ptafr
platelet-activating factor receptor
treatment
ISO
mRNA:decreased expression:cerebral cortex (rat)
RGD
PMID:17268849 PMID:8158141
RGD:9999221 , RGD:10043297
NCBI chr 4:132,291,378...132,309,994
Ensembl chr 4:132,291,378...132,309,994
G
Pten
phosphatase and tensin homolog
ISO
RGD
PMID:12414116
RGD:1358425
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
G
Ptger4
prostaglandin E receptor 4 (subtype EP4)
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:16437207
RGD:10043375
NCBI chr15:5,262,880...5,273,668
Ensembl chr15:5,236,142...5,273,668
G
Ptn
pleiotrophin
ISO
mRNA:increased expression:cerebral cortex, vasculature, macrophage (rat)
RGD
PMID:9570800
RGD:9831440
NCBI chr 6:36,691,863...36,787,114
Ensembl chr 6:36,691,864...36,787,155
G
Ptpn13
protein tyrosine phosphatase, non-receptor type 13
ISO
mRNA,protein:increased expression:cerebral cortex:
RGD
PMID:18096138
RGD:4142863
NCBI chr 5:103,573,058...103,746,227
Ensembl chr 5:103,573,058...103,746,169
G
Ptpn5
protein tyrosine phosphatase, non-receptor type 5
treatment severity
ISO IMP
protein:decreased phosphorylation, decreased expression:striatum (rat)
RGD
PMID:24198371 PMID:24198371 PMID:24198371
RGD:9835010 , RGD:9835010 , RGD:9835010
NCBI chr 7:46,727,543...46,783,774
Ensembl chr 7:46,727,543...46,783,432
G
Rack1
receptor for activated C kinase 1
ISO
RGD
PMID:24007266
RGD:9588303
NCBI chr11:48,691,187...48,697,068
Ensembl chr11:48,691,159...48,697,261
G
Robo1
roundabout guidance receptor 1
disease_progression
ISO IEP
protein:increased expression:hippocampus protein:increased expression:brain, astrocyte
RGD
PMID:26764532 PMID:27686659 PMID:23473743
RGD:11573340 , RGD:243048429 , RGD:243048431
NCBI chr16:71,824,406...72,844,379
Ensembl chr16:72,105,194...72,842,983
G
Robo2
roundabout guidance receptor 2
ISO
protein:increased expression:brain, astrocyte
RGD
PMID:27686659
RGD:243048429
NCBI chr16:73,688,725...75,244,331
Ensembl chr16:73,688,727...74,208,713
G
Robo4
roundabout guidance receptor 4
ISO
protein:increased expression:hippocampus
RGD
PMID:26764532
RGD:11573340
NCBI chr 9:37,313,198...37,325,319
Ensembl chr 9:37,313,193...37,326,411
G
Rps6
ribosomal protein S6
ISO
RGD
PMID:26556340
RGD:11041643
NCBI chr 4:86,772,336...86,775,604
Ensembl chr 4:86,772,897...86,775,649
G
Sema3e
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
disease_progression
ISO
RGD
PMID:30653356
RGD:155663383
NCBI chr 5:14,075,290...14,306,703
Ensembl chr 5:14,075,290...14,306,703
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
treatment
ISO
RGD
PMID:26851971
RGD:11073692
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Serpinf1
serine (or cysteine) peptidase inhibitor, clade F, member 1
treatment
ISO
human gene in a rat model
RGD
PMID:18624913
RGD:8613878
NCBI chr11:75,300,855...75,313,449
Ensembl chr11:75,300,595...75,313,527
G
Sgk1
serum/glucocorticoid regulated kinase 1
ISO
mRNA:increased expression:hippocampus, pyramidal cell
RGD
PMID:15046873
RGD:1580967
NCBI chr10:21,758,083...21,875,802
Ensembl chr10:21,758,083...21,875,802
G
Sin3a
transcriptional regulator, SIN3A (yeast)
ISO
RGD
PMID:24063527
RGD:9495912
NCBI chr 9:56,979,271...57,035,652
Ensembl chr 9:56,979,324...57,035,650
G
Sirt6
sirtuin 6
ISO
mRNA, protein:decreased expression:brain
RGD
PMID:23899523
RGD:9586062
NCBI chr10:81,457,621...81,463,631
Ensembl chr10:81,457,619...81,463,631
G
Slc12a2
solute carrier family 12, member 2
ISO
RGD
PMID:27798271
RGD:14398833
NCBI chr18:58,011,505...58,079,893
Ensembl chr18:58,011,750...58,079,893
G
Slc17a6
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6
ISO
RGD
PMID:23458738
RGD:9999193
NCBI chr 7:51,271,578...51,320,874
Ensembl chr 7:51,271,754...51,320,867
G
Slc17a7
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7
ISO
RGD
PMID:23458738
RGD:9999193
NCBI chr 7:44,813,345...44,825,563
Ensembl chr 7:44,813,373...44,825,566
G
Slc17a8
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8
ISO
RGD
PMID:23458738
RGD:9999193
NCBI chr10:89,409,882...89,457,111
Ensembl chr10:89,409,882...89,457,115
G
Slit2
slit guidance ligand 2
ISO
protein:increased expression:hippocampus protein:increased expression:brain, astrocyte
RGD
PMID:26764532 PMID:27686659
RGD:11573340 , RGD:243048429
NCBI chr 5:48,138,633...48,465,077
Ensembl chr 5:48,140,480...48,465,075
G
Smpd3
sphingomyelin phosphodiesterase 3, neutral
ISO
RGD
PMID:24007266
RGD:9588303
NCBI chr 8:106,979,180...107,064,597
Ensembl chr 8:106,979,180...107,064,620
G
Socs1
suppressor of cytokine signaling 1
treatment
ISO
RGD
PMID:33081480
RGD:151347423
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
G
Sod1
superoxide dismutase 1, soluble
treatment
ISO
human protein in a rat model human gene in a rat model CTD Direct Evidence: therapeutic
CTD RGD
PMID:12629175 PMID:15829915 PMID:16538228 PMID:16868554 PMID:21531066 PMID:17110031 More...
RGD:8655885 , RGD:8655986
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sod2
superoxide dismutase 2, mitochondrial
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11333366 PMID:30716316
RGD:27095883
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Stat3
signal transducer and activator of transcription 3
exacerbates
ISO
RGD
PMID:23764464 PMID:23884942
RGD:8694326 , RGD:8694331
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
G
Tert
telomerase reverse transcriptase
treatment
ISO
RGD
PMID:21914402
RGD:11038669
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
G
Tfpi
tissue factor pathway inhibitor
treatment
ISO
RGD
PMID:18067952
RGD:11062087
NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
G
Tia1
cytotoxic granule-associated RNA binding protein 1
ISO
RGD
PMID:16055272
RGD:10059581
NCBI chr 6:86,381,001...86,410,387
Ensembl chr 6:86,381,201...86,410,387
G
Tial1
Tia1 cytotoxic granule-associated RNA binding protein-like 1
ISO
RGD
PMID:10700014
RGD:1357161
NCBI chr 7:128,041,496...128,063,450
Ensembl chr 7:128,041,501...128,063,441
G
Tnf
tumor necrosis factor
treatment
ISO
mRNA:increased expression:striatum,hippocampus:
RGD
PMID:24053818 PMID:11412877
RGD:7364868 , RGD:13825263
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
treatment
ISO
mRNA:increased expression:striatum,hippocampus:
RGD
PMID:21868309 PMID:11412877
RGD:8661762 , RGD:13825263
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
treatment
ISO IMP
RGD
PMID:23435869 PMID:23043486 PMID:20811149
RGD:7247582 , RGD:7247583 , RGD:7247585
NCBI chr 9:8,543,868...8,680,753
Ensembl chr 9:8,544,143...8,680,742
G
Trpm2
transient receptor potential cation channel, subfamily M, member 2
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:16777714
RGD:10003026
NCBI chr10:77,743,556...77,805,746
Ensembl chr10:77,743,556...77,806,397
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
IMP
RGD
PMID:22284622
RGD:7175554
NCBI chr11:73,158,315...73,191,194
Ensembl chr11:73,158,214...73,191,189
G
Ucp2
uncoupling protein 2 (mitochondrial, proton carrier)
treatment
ISO
RGD
PMID:19772611
RGD:7204428
NCBI chr 7:100,142,565...100,148,832
Ensembl chr 7:100,142,544...100,151,227
G
Vwf
Von Willebrand factor
treatment
ISO
RGD
PMID:22771326
RGD:7207039
NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
G
Wnk1
WNK lysine deficient protein kinase 1
ISO
RGD
PMID:27798271
RGD:14398833
NCBI chr 6:119,900,930...120,015,659
Ensembl chr 6:119,900,930...120,015,633
G
Wnk2
WNK lysine deficient protein kinase 2
ISO
RGD
PMID:27798271
RGD:14398833
NCBI chr13:49,189,778...49,302,110
Ensembl chr13:49,189,779...49,301,490
G
Wnk4
WNK lysine deficient protein kinase 4
ISO
RGD
PMID:27798271
RGD:14398833
NCBI chr11:101,151,363...101,168,235
Ensembl chr11:101,151,393...101,168,235
G
Xrcc1
X-ray repair complementing defective repair in Chinese hamster cells 1
treatment
ISO
RGD
PMID:19840223
RGD:2325713
NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all